SLE and antiphospholipid syndrome: 168. Dyslipidaemia, Hyperhomocysteinaemia and Antiphospholipid Antibodies as Risk Factors of Thrombotic Complications in Patients with Systemic Lupus Erythematosus
Shevchuk, S., Segeda, I., Kuvikova, I., Shevchuk, O., Segeda, S., Kurylenko, I., Lutalo, P. M., D'Cruz, D. P., Zakalka, M., Trivellas, T., Sangle, S. R., Bertolaccini, M. L., D' Cruz, D. P., Davies, R. J., Lin Loh, Y., Sanchez, E., Renau Escrig, A. I., Isenberg, D., Jordan, N., Karim, Y., Abbs, I., D'Cruz, D., Rajasekhar, L. S., Habibi, S., Durga, P., Kanchinadham, S., Agrawal, S., Gumdal, N., Al-Husain, A. Z., Charlton-Menys, V., Haque, S., Rakieh, C., Shelmerdine, J., Durrington, P., Bruce, I. N., Parker, B., Zaki, A., Alexander, Y., Gayed, M., Toescu, V., Leone, F., Khamashta, M., Gordon, C.
Published in Rheumatology (Oxford, England) (01.04.2011)
Published in Rheumatology (Oxford, England) (01.04.2011)
Get full text
Journal Article